TIMP3 and neoplasm: TIMP-3-armed HSV treatment of human neural tumor cells in vitro and in vivo inhibited MMP3 levels, increased viral replication in and cytotoxicity of tumor cells as well as VECs, thereby reducing vascular density [82].